MA27685A1 - Nouvelle souche de bacterie acide lactique et compositions comestibles, medicaments et produits veterinaires la contenant - Google Patents

Nouvelle souche de bacterie acide lactique et compositions comestibles, medicaments et produits veterinaires la contenant

Info

Publication number
MA27685A1
MA27685A1 MA27666A MA27666A MA27685A1 MA 27685 A1 MA27685 A1 MA 27685A1 MA 27666 A MA27666 A MA 27666A MA 27666 A MA27666 A MA 27666A MA 27685 A1 MA27685 A1 MA 27685A1
Authority
MA
Morocco
Prior art keywords
lactic acid
acid bacteria
new strain
edible compositions
products
Prior art date
Application number
MA27666A
Other languages
English (en)
Inventor
Simone Claudio De
Original Assignee
Actial Farmaceutica Lda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actial Farmaceutica Lda filed Critical Actial Farmaceutica Lda
Publication of MA27685A1 publication Critical patent/MA27685A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/249—Thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/529—Infantis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
MA27666A 2001-12-21 2004-05-04 Nouvelle souche de bacterie acide lactique et compositions comestibles, medicaments et produits veterinaires la contenant MA27685A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001RM000763A ITRM20010763A1 (it) 2001-12-21 2001-12-21 Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.

Publications (1)

Publication Number Publication Date
MA27685A1 true MA27685A1 (fr) 2006-01-02

Family

ID=11455924

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27666A MA27685A1 (fr) 2001-12-21 2004-05-04 Nouvelle souche de bacterie acide lactique et compositions comestibles, medicaments et produits veterinaires la contenant

Country Status (29)

Country Link
US (2) US7223591B2 (fr)
EP (2) EP1652913A1 (fr)
JP (2) JP4339124B2 (fr)
KR (1) KR100934747B1 (fr)
CN (2) CN100502893C (fr)
AR (1) AR038036A1 (fr)
AT (1) ATE335807T1 (fr)
AU (1) AU2002367124B2 (fr)
BR (1) BR0207397A (fr)
CA (1) CA2457801C (fr)
CY (1) CY1105402T1 (fr)
DE (1) DE60213859T2 (fr)
DK (1) DK1456351T3 (fr)
EA (1) EA006688B1 (fr)
ES (1) ES2271384T3 (fr)
HK (2) HK1072958A1 (fr)
HU (1) HU225787B1 (fr)
IL (2) IL161995A0 (fr)
IS (1) IS2645B (fr)
IT (1) ITRM20010763A1 (fr)
MA (1) MA27685A1 (fr)
MX (1) MXPA03007483A (fr)
NO (1) NO329645B1 (fr)
NZ (1) NZ533696A (fr)
PL (1) PL207395B1 (fr)
PT (1) PT1456351E (fr)
UA (1) UA80546C2 (fr)
WO (1) WO2003055984A1 (fr)
ZA (1) ZA200405763B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
US20050239706A1 (en) * 2003-10-31 2005-10-27 Washington University In St. Louis Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
WO2008028300A1 (fr) * 2006-09-07 2008-03-13 Mcgill University Formulation orale comprenant des bactéries produisant de la féruloyl estérase dans une membrane polymère
US8747836B2 (en) 2008-01-15 2014-06-10 Sapporo Breweries Limited Agent for prevention of alcoholic hepatopathy
WO2010108865A1 (fr) 2009-03-25 2010-09-30 Chr. Hansen A/S Utilisation de probiotiques pour amélioration de la résistance à l'insuline induite par régime
TW201106957A (en) * 2009-08-31 2011-03-01 Synbio Tech Inc The new strain of Lactobacillus plantarum LP28 and its use in treating allergy
CN102702372B (zh) * 2010-10-28 2013-11-27 内蒙古蒙牛乳业（集团）股份有限公司 一种嗜热链球菌胞外多糖及其制备和检测方法
KR101238836B1 (ko) 2011-05-17 2013-03-04 삼육대학교산학협력단 혼합 유산균을 포함하는 비만 또는 비만 관련 질환 치료 또는 예방용 약제학적 조성물 또는 식품 조성물
EP2609814A1 (fr) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 pour le développement de la fonction cognitive
JP6061530B2 (ja) * 2012-07-25 2017-01-18 株式会社ヤクルト本社 Ｎａｓｈ予防治療剤
CN104968780A (zh) 2012-09-20 2015-10-07 普洛特拉有限公司 用于治疗肥胖和肥胖相关病症的益生菌组合物和方法
KR101545551B1 (ko) 2013-12-12 2015-08-19 주식회사한국야쿠르트 인슐린 저항성 개선 효능을 갖는 7종의 유산균 복합균주를 유효성분으로 함유하는 조성물
KR101426275B1 (ko) 2014-04-04 2014-08-06 주식회사한국야쿠르트 지방합성 억제 및 지방산화 촉진에 의한 체지방 감소 효능을 갖는 5종의 유산균 복합균주를 유효성분으로 함유하는 조성물
WO2015182155A1 (fr) * 2014-05-29 2015-12-03 日東薬品工業株式会社 Nouvelle bactérie d'acide lactique et composition comprenant cette bactérie d'acide lactique
EP3172973B1 (fr) * 2015-11-27 2020-04-08 DAFLORN Ltd. Formule probiotique, procédé pour sa préparation et son utilisation
BR112018070518A2 (pt) * 2016-04-14 2019-01-29 Dupont Nutrition Biosci Aps bactéria do gênero bifidobacterium, usos de uma bactéria do gênero bifidobacterium e método para reduzir a ingestão de alimentos, energia e/ou gordura
JPWO2018174125A1 (ja) * 2017-03-22 2020-01-23 雪印メグミルク株式会社 脂質代謝改善用組成物
KR102218992B1 (ko) 2017-12-12 2021-02-23 한국생명공학연구원 아가토바쿨룸 속 균주를 유효성분으로 함유하는 자폐 범주성 장애의 예방, 개선 또는 치료용 조성물
KR102021881B1 (ko) * 2018-09-07 2019-09-17 재단법인 전남생물산업진흥원 스트렙토코커스 써모필러스 lm1012 균주 및 이를 포함하는 염증 질환 또는 대사 질환의 예방 또는 치료용 조성물
CN113025527A (zh) * 2021-03-25 2021-06-25 上海市第十人民医院 一种用来预测婴幼儿肥胖病的乳源性唾液链球菌及其分离方法
CN115181698B (zh) * 2022-06-28 2023-09-08 广东粤港澳大湾区国家纳米科技创新研究院 一种益生菌组合物及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61221124A (ja) * 1985-03-26 1986-10-01 Advance Res & Dev Co Ltd 肝機能改善剤
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
US6297229B1 (en) * 1994-11-14 2001-10-02 Mayo Foundation For Medical Education And Research Use of ursodeoxycholic acid to treat nonalcoholic steatohepatitis
US5760010A (en) 1995-01-01 1998-06-02 Klein; Ira Method of treating liver disorders with a macrolide antibiotic
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
WO1999029330A1 (fr) * 1997-12-05 1999-06-17 Viva America Marketing, Inc. Composition et procede servant a traiter des steatohepatites non alcooliques
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
IT1309427B1 (it) * 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
ITRM20010763A1 (it) 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.

Also Published As

Publication number Publication date
EA006688B1 (ru) 2006-02-24
EP1652913A1 (fr) 2006-05-03
PT1456351E (pt) 2006-10-31
UA80546C2 (en) 2007-10-10
CN100502893C (zh) 2009-06-24
HK1072958A1 (en) 2005-09-16
JP4339124B2 (ja) 2009-10-07
NO329645B1 (no) 2010-11-22
US20040248278A1 (en) 2004-12-09
JP2005512590A (ja) 2005-05-12
NO20033621L (no) 2003-08-14
CN1558946A (zh) 2004-12-29
HUP0402460A3 (en) 2005-04-28
EA200400845A1 (ru) 2004-12-30
BR0207397A (pt) 2004-02-10
CN1276970C (zh) 2006-09-27
JP2009183296A (ja) 2009-08-20
CA2457801A1 (fr) 2003-07-10
ITRM20010763A1 (it) 2003-06-21
DE60213859D1 (de) 2006-09-21
EP1456351B1 (fr) 2006-08-09
CA2457801C (fr) 2013-06-04
HU225787B1 (hu) 2007-09-28
IS7229A (is) 2004-04-21
NO20033621D0 (no) 2003-08-14
DE60213859T2 (de) 2007-02-08
HK1100165A1 (en) 2007-09-07
ZA200405763B (en) 2006-07-26
PL370252A1 (en) 2005-05-16
US7223591B2 (en) 2007-05-29
IS2645B (is) 2010-08-15
CY1105402T1 (el) 2010-04-28
KR20040074053A (ko) 2004-08-21
AU2002367124A1 (en) 2003-07-15
IL161995A (en) 2010-11-30
AR038036A1 (es) 2004-12-22
US20070253934A1 (en) 2007-11-01
DK1456351T3 (da) 2006-12-11
WO2003055984A1 (fr) 2003-07-10
HUP0402460A2 (hu) 2005-03-29
PL207395B1 (pl) 2010-12-31
US7628981B2 (en) 2009-12-08
MXPA03007483A (es) 2003-12-04
CN1875994A (zh) 2006-12-13
KR100934747B1 (ko) 2009-12-30
ATE335807T1 (de) 2006-09-15
NZ533696A (en) 2005-12-23
EP1456351A1 (fr) 2004-09-15
AU2002367124B2 (en) 2007-11-29
IL161995A0 (en) 2005-11-20
ES2271384T3 (es) 2007-04-16

Similar Documents

Publication Publication Date Title
MA27685A1 (fr) Nouvelle souche de bacterie acide lactique et compositions comestibles, medicaments et produits veterinaires la contenant
WO2006053761A3 (fr) Gommes naturelles modifiees pour preparations de principes actifs
DK1395269T3 (da) Lipoteichoinsyre fra mælkesyrebakterier til anvendelse som lægemiddel og i behandling af baktielle sygdomme
HUP0202342A2 (hu) Esszenciális zsírsavakat és homociszteinszint csökkentő hatóanyagokat tartalmazó gyógyászati és élelmiszer-készítmények
DE602004027476D1 (de) Zusammensetzungen und formulierungsverfahren für enteralprodukte, die sialsäure enthalten
EP0922395A4 (fr) Produit comprenant un ingredient favorable a la sante et son procede de production
WO2005053710A3 (fr) Glucosamine
KR20100016416A (ko) 리소자임 및 ｃ-1/ｃ-4 다당류를 함유하는 조성물, 및 구강 관리, 미용학 및 피부과, 피임, 비뇨기과 및 부인과에서의 이의 용도
JP2020536858A (ja) 改善されたバイオアベイラビリティーを有するハーブ組成物
FR2844514B1 (fr) Produit immunogene stable comprenant des heterocomplexes antigeniques, compositions les contenant et procede de preparation
HUP0202395A2 (hu) Szőlőmagok, hidegen préselt szőlőmagolaj, szőlőmagdara és szőlőmagliszt
JP2007523891A5 (fr)
SI1951290T1 (en) A device for use in the case of fructose intolerance
FR2866564B1 (fr) Desinfectant antiseptique et produit cosmetique, produit pharmaceutique ou aliment le contenant
WO2004019800A3 (fr) Produit rafraichisseur d'haleine et d'hygiene buccale
CA2539706A1 (fr) Produit comestible contenant des microcapsules aromatisantes
WO2003050067A3 (fr) Analogues de la vitamine d
WO2004019867A3 (fr) Produit purifiant l'haleine et produit purificateur buccal a l'essence de cardamome
ITBO20020065A0 (it) Unita' e metodo di riordino di prodotti dolciari , quali caramelle e simili
IL166097A0 (en) Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole preparation process and intermediates of this process their use as medicaments and pharmaceutical compositions comprising them
KR102614880B1 (ko) 구강용 조성물 및 구강 내 상재균의 생육 촉진제
WO2005012210A3 (fr) Preparations a activite antimicrobienne
WO2004093564A3 (fr) Systeme de distribution d'ingredient particulaire
JP7333751B2 (ja) ヒト抗菌ペプチド産生促進剤
SI1456351T1 (sl) Nova sev mlecnokislinske bakterije in uzitne zmesi, zdravila in veterinarski proizvodi, ki jo vsebujejo